Comparative analysis of daptomycin and vancomycin in the treatment of vertebral osteomyelitis

Gopikishan Rangaraj, Kerry Cleveland, Michael Gelfand

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Vertebral osteomyelitis is caused predominantly by Staphylococcus aureus, which is increasingly methicillin resistant. Our objective was to compare outcomes after use of vancomycin and daptomycin for treatment of vertebral osteomyelitis. Methods: We conducted a retrospective chart review of all patients who received a diagnosis of vertebral osteomyelitis over a 6-year period at a tertiary care hospital in Memphis, Tennessee. Results: Sixty-one patients were identified who received either vancomycin (n = 30) or daptomycin (n = 31) for vertebral osteomyelitis and had a follow-up period of at least 12 months. The mean duration of antibiotic therapy was 41 days in the vancomycin group and 45 days in the daptomycin group. Methicillin-resistant Staphylococcus aureus was identified in 81% of the vancomycin-treated patients and in 86% of the daptomycin-treated patients. Cure was significantly more likely to be obtained in the patients receiving daptomycin (97%) than in the patients treated with vancomycin (70%) (P = 0.0057). Conclusions: When the mean duration of parenteral vancomycin or daptomycin approximates 6 weeks, cure rates for vertebral osteomyelitis equal or exceed 70%. The use of daptomycin resulted in a significantly higher rate of cure compared with that of vancomycin.

Original languageEnglish (US)
Pages (from-to)219-222
Number of pages4
JournalInfectious Diseases in Clinical Practice
Volume22
Issue number4
DOIs
StatePublished - Jan 1 2014

Fingerprint

Daptomycin
Osteomyelitis
Vancomycin
Therapeutics
Methicillin Resistance
Tertiary Healthcare
Methicillin-Resistant Staphylococcus aureus
Tertiary Care Centers
Staphylococcus aureus
Anti-Bacterial Agents

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Comparative analysis of daptomycin and vancomycin in the treatment of vertebral osteomyelitis. / Rangaraj, Gopikishan; Cleveland, Kerry; Gelfand, Michael.

In: Infectious Diseases in Clinical Practice, Vol. 22, No. 4, 01.01.2014, p. 219-222.

Research output: Contribution to journalArticle

@article{547616988be64eab89e2357b5e25b7dc,
title = "Comparative analysis of daptomycin and vancomycin in the treatment of vertebral osteomyelitis",
abstract = "Background: Vertebral osteomyelitis is caused predominantly by Staphylococcus aureus, which is increasingly methicillin resistant. Our objective was to compare outcomes after use of vancomycin and daptomycin for treatment of vertebral osteomyelitis. Methods: We conducted a retrospective chart review of all patients who received a diagnosis of vertebral osteomyelitis over a 6-year period at a tertiary care hospital in Memphis, Tennessee. Results: Sixty-one patients were identified who received either vancomycin (n = 30) or daptomycin (n = 31) for vertebral osteomyelitis and had a follow-up period of at least 12 months. The mean duration of antibiotic therapy was 41 days in the vancomycin group and 45 days in the daptomycin group. Methicillin-resistant Staphylococcus aureus was identified in 81{\%} of the vancomycin-treated patients and in 86{\%} of the daptomycin-treated patients. Cure was significantly more likely to be obtained in the patients receiving daptomycin (97{\%}) than in the patients treated with vancomycin (70{\%}) (P = 0.0057). Conclusions: When the mean duration of parenteral vancomycin or daptomycin approximates 6 weeks, cure rates for vertebral osteomyelitis equal or exceed 70{\%}. The use of daptomycin resulted in a significantly higher rate of cure compared with that of vancomycin.",
author = "Gopikishan Rangaraj and Kerry Cleveland and Michael Gelfand",
year = "2014",
month = "1",
day = "1",
doi = "10.1097/IPC.0000000000000116",
language = "English (US)",
volume = "22",
pages = "219--222",
journal = "Infectious Diseases in Clinical Practice",
issn = "1056-9103",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Comparative analysis of daptomycin and vancomycin in the treatment of vertebral osteomyelitis

AU - Rangaraj, Gopikishan

AU - Cleveland, Kerry

AU - Gelfand, Michael

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background: Vertebral osteomyelitis is caused predominantly by Staphylococcus aureus, which is increasingly methicillin resistant. Our objective was to compare outcomes after use of vancomycin and daptomycin for treatment of vertebral osteomyelitis. Methods: We conducted a retrospective chart review of all patients who received a diagnosis of vertebral osteomyelitis over a 6-year period at a tertiary care hospital in Memphis, Tennessee. Results: Sixty-one patients were identified who received either vancomycin (n = 30) or daptomycin (n = 31) for vertebral osteomyelitis and had a follow-up period of at least 12 months. The mean duration of antibiotic therapy was 41 days in the vancomycin group and 45 days in the daptomycin group. Methicillin-resistant Staphylococcus aureus was identified in 81% of the vancomycin-treated patients and in 86% of the daptomycin-treated patients. Cure was significantly more likely to be obtained in the patients receiving daptomycin (97%) than in the patients treated with vancomycin (70%) (P = 0.0057). Conclusions: When the mean duration of parenteral vancomycin or daptomycin approximates 6 weeks, cure rates for vertebral osteomyelitis equal or exceed 70%. The use of daptomycin resulted in a significantly higher rate of cure compared with that of vancomycin.

AB - Background: Vertebral osteomyelitis is caused predominantly by Staphylococcus aureus, which is increasingly methicillin resistant. Our objective was to compare outcomes after use of vancomycin and daptomycin for treatment of vertebral osteomyelitis. Methods: We conducted a retrospective chart review of all patients who received a diagnosis of vertebral osteomyelitis over a 6-year period at a tertiary care hospital in Memphis, Tennessee. Results: Sixty-one patients were identified who received either vancomycin (n = 30) or daptomycin (n = 31) for vertebral osteomyelitis and had a follow-up period of at least 12 months. The mean duration of antibiotic therapy was 41 days in the vancomycin group and 45 days in the daptomycin group. Methicillin-resistant Staphylococcus aureus was identified in 81% of the vancomycin-treated patients and in 86% of the daptomycin-treated patients. Cure was significantly more likely to be obtained in the patients receiving daptomycin (97%) than in the patients treated with vancomycin (70%) (P = 0.0057). Conclusions: When the mean duration of parenteral vancomycin or daptomycin approximates 6 weeks, cure rates for vertebral osteomyelitis equal or exceed 70%. The use of daptomycin resulted in a significantly higher rate of cure compared with that of vancomycin.

UR - http://www.scopus.com/inward/record.url?scp=84905578044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905578044&partnerID=8YFLogxK

U2 - 10.1097/IPC.0000000000000116

DO - 10.1097/IPC.0000000000000116

M3 - Article

VL - 22

SP - 219

EP - 222

JO - Infectious Diseases in Clinical Practice

JF - Infectious Diseases in Clinical Practice

SN - 1056-9103

IS - 4

ER -